Robotic Ankle Assistance + Audiovisual Biofeedback for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help children with cerebral palsy (CP) improve their walking. Researchers are testing how well children with CP can adapt their movement using a treadmill and special feedback tools, such as an ankle exoskeleton and audiovisual biofeedback. They seek to determine if repeated training or surgery can improve walking in these children. The trial is recruiting children with CP who have difficulty walking and have not recently undergone major leg surgery or specific treatments. Participants will either undergo orthopedic surgery or complete treadmill sessions with feedback to assess changes in movement. As an unphased trial, this study offers a unique opportunity for children to potentially enhance their walking abilities through innovative methods.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants should not have had botulinum toxin injections in the prior 3 months.
What prior data suggests that this robotic ankle assistance and audiovisual biofeedback are safe for children with cerebral palsy?
Research has shown that biofeedback, which provides children with cerebral palsy (CP) real-time information about their movements, is generally well-tolerated. Studies have found that while results can vary, this method helps children improve their walking by better engaging their muscles. Significant reports of harm have not emerged, suggesting it is safe to try.
Robotic ankle resistance, a wearable device that aids walking, also showed promise in previous studies. Research indicates that this assistance can improve walking speed and distance in children with CP. No major safety issues were reported, suggesting it is generally safe to use.
Overall, both biofeedback and robotic ankle resistance treatments appear safe, with no major problems reported in earlier research.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for cerebral palsy because they combine cutting-edge technology with personalized feedback to improve walking abilities. Unlike traditional therapies that often rely on physical exercises alone, this approach uses a robotic ankle exoskeleton to provide resistance during walking, helping to strengthen muscles and improve gait. Additionally, the integration of audiovisual biofeedback offers real-time insights into muscle activity, allowing participants to adjust their movements effectively. This innovative method has the potential to enhance rehabilitation outcomes by making therapy more interactive and targeted.
What evidence suggests that this trial's treatments could be effective for cerebral palsy?
Research has shown that audiovisual biofeedback, one of the treatments in this trial, can help people with cerebral palsy (CP) walk better. Studies have found that biofeedback significantly increases ankle strength during walking, improving movement. However, results can vary widely among individuals.
Regarding the robotic ankle support, another treatment option in this trial, studies suggest it can ease walking by reducing the effort needed at the ankle by about 12%. This assistance has increased walking speed, distance, and stride length. Together, these treatments offer hope for helping children with CP improve their walking abilities.13678Who Is on the Research Team?
Katherine M Steele, PhD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for children with bilateral cerebral palsy affecting both legs, who can walk but have some limitations (GMFCS Level II). They shouldn't have had leg surgery or injuries in the last year, botulinum toxin injections in the past 3 months, prior selective dorsal rhizotomy surgery, seizures or heart conditions that limit treadmill use, or current pain impacting walking.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 6-8 weeks of multimodal biofeedback training or orthopedic surgery
Follow-up
Participants are monitored for changes in gait and adaptation rates after treatment
Open-label extension (optional)
Participants may continue to receive feedback training to further enhance walking function
What Are the Treatments Tested in This Trial?
Interventions
- Audiovisual Biofeedback
- Biomotum Spark: Robotic ankle resistance
- Gait Adaptation and Biofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Gillette Children's
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Gillette Children's Specialty Healthcare
Collaborator
Northern Arizona University
Collaborator